Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National
Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…
Will blockbuster obesity drugs revolutionize addiction treatment?
Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction…
Early-life nutrition | National Institutes of Health (NIH)
Research in Context November 25, 2025 Exposures in the womb can affect lifelong health Nutrition matters, and what young,…
Lilly cuts price for obesity drug Zepbound
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…
Simple food swaps can lower risk of chronic diseases, doctor says
NEWYou can now listen to Fox News articles! Nutrition can be the key to warding off disease —…
Alternate-day fasting cuts body fat but also reduces muscle
Nov 28 2025 New research shows that while four weeks of alternate-day fasting can quickly reduce body weight…
Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
Milkshakes and lattes slapped with UK sugar tax, health secretary confirms – POLITICO
“Obesity robs children of the best possible start in life,” Streeting told MPs Tuesday. “It hits the poorest…
Doctor Weight loss drugs look set to be made more affordable – we need to do the same for healthy food – The Journal
Doctor Weight loss drugs look set to be made more affordable – we need to do the same…
Anaesthetists forced to cancel procedures because of patients keeping quiet about GLP-1 receptor agonists
A growing trend of patients arriving for surgery without telling doctors they are taking GLP-1 receptor agonists is…
Ozempic’s Latest Weight Loss Competition Is Like Nothing We’ve Seen Before
The race to develop the next generation of weight loss drugs has taken an interesting new turn. In…